|
|
||||||||
From the Departments of Neurology (Drs. Singhal, Caviness, Begleiter, Rordorf, and Koroshetz) and Pathology (Dr. Mark), Massachusetts General Hospital, Boston, MA.
Address correspondence and reprint requests to Dr. A.B. Singhal, Stroke Service, VBK-802, Massachusetts General Hospital, 55 Fruit Street, Boston, MA 02114; e-mail: asinghal{at}partners.org
Serotonin (5-hydroxytryptamine) is a potent vasoconstrictor amine. The authors report three patients who developed thunderclap headache, reversible cerebral arterial vasoconstriction, and ischemic strokes (i.e., the CallFleming syndrome). The only cause for vasoconstriction was recent exposure to serotonergic drugs in all patients, and to pseudoephedrine in one patient. These cases, and the literature, suggest that the use of serotonin-enhancing drugs can precipitate a cerebrovascular syndrome due to reversible, multifocal arterial narrowing.
This article has been cited by other articles:
![]() |
R R Moustafa, C M C Allen, and J-C Baron Call-Fleming syndrome associated with subarachnoid haemorrhage: three new cases J. Neurol. Neurosurg. Psychiatry, May 1, 2008; 79(5): 602 - 605. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Ducros, M. Boukobza, R. Porcher, M. Sarov, D. Valade, and M.-G. Bousser The clinical and radiological spectrum of reversible cerebral vasoconstriction syndrome. A prospective series of 67 patients Brain, December 1, 2007; 130(12): 3091 - 3101. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.H. Rosenbloom and A.B. Singhal CT Angiography and Diffusion-Perfusion MR Imaging in a Patient with Ipsilateral Reversible Cerebral Vasoconstriction after Carotid Endarterectomy AJNR Am. J. Neuroradiol., May 1, 2007; 28(5): 920 - 922. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. H. Calabrese, D. W. Dodick, T. J. Schwedt, and A. B. Singhal Narrative Review: Reversible Cerebral Vasoconstriction Syndromes Ann Intern Med, January 2, 2007; 146(1): 34 - 44. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Noskin, E. Jafarimojarrad, R. B. Libman, and J. L. Nelson Diffuse cerebral vasoconstriction (Call-Fleming syndrome) and stroke associated with antidepressants. Neurology, July 11, 2006; 67(1): 159 - 160. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. B. Singhal, M. A. Topcuoglu, D. J. Dorer, C. S. Ogilvy, B. S. Carter, and W. J. Koroshetz SSRI and statin use increases the risk for vasospasm after subarachnoid hemorrhage Neurology, March 22, 2005; 64(6): 1008 - 1013. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. A Traino, N. A Buckley, and M. L Bassett Probable Ischemic Colitis Caused by Pseudoephedrine with Tramadol as a Possible Contributing Factor Ann. Pharmacother., December 1, 2004; 38(12): 2068 - 2070. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Ramasubbu SSRI Treatment-Associated Stroke: Causality Assessment in Two Cases Ann. Pharmacother., July 1, 2004; 38(7): 1197 - 1201. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. H Manos and S. M Wechsler Transient Ischemic Attack Reported with Paroxetine Use Ann. Pharmacother., April 1, 2004; 38(4): 617 - 620. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. B. Singhal Postpartum Angiopathy With Reversible Posterior Leukoencephalopathy Arch Neurol, March 1, 2004; 61(3): 411 - 416. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Cambj-Sapunar, M. Yu, D. R. Harder, and R. J. Roman Contribution of 5-Hydroxytryptamine1B Receptors and 20-Hydroxyeiscosatetraenoic Acid to Fall in Cerebral Blood Flow After Subarachnoid Hemorrhage Stroke, May 1, 2003; 34(5): 1269 - 1275. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. J. Gilbert, D. J. Petro, and A. B. Singhal Cerebral vasoconstriction and stroke after use of serotonergic drugs Neurology, August 27, 2002; 59(4): 651 - 652. [Full Text] [PDF] |
||||
![]() |
A B Singhal and D W Dodick Thunderclap headache, reversible cerebral arterial vasoconstriction, and unruptured aneurysms J. Neurol. Neurosurg. Psychiatry, July 1, 2002; 73(1): 96 - 96. [Full Text] [PDF] |
||||
![]() |
J. Rosack Rare Neurologic Syndrome Linked to Antidepressants Psychiatr News, March 15, 2002; 37(6): 31 - 31. [Full Text] |
||||
Read all Correspondence
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |